abrdn Healthcare Investors (HQH) Competitors

abrdn Healthcare Investors logo
$20.57 -0.03 (-0.15%)
Closing price 03:59 PM Eastern
Extended Trading
$20.64 +0.07 (+0.34%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HQH vs. MRX, FHI, PIPR, LAZ, and MC

Should you buy abrdn Healthcare Investors stock or one of its competitors? abrdn Healthcare Investors's main competitors and comparable companies include Marex Group plc Ordinary Shares (MRX), Federated Hermes (FHI), Piper Sandler Companies (PIPR), Lazard (LAZ), and Moelis & Company (MC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does abrdn Healthcare Investors compare to Marex Group plc Ordinary Shares?

Marex Group plc Ordinary Shares (NASDAQ:MRX) and abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

32.6% of abrdn Healthcare Investors shares are owned by institutional investors. 7.3% of abrdn Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, abrdn Healthcare Investors had 2 more articles in the media than Marex Group plc Ordinary Shares. MarketBeat recorded 4 mentions for abrdn Healthcare Investors and 2 mentions for Marex Group plc Ordinary Shares. Marex Group plc Ordinary Shares' average media sentiment score of 1.12 beat abrdn Healthcare Investors' score of 0.60 indicating that Marex Group plc Ordinary Shares is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Marex Group plc Ordinary Shares
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
abrdn Healthcare Investors
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Marex Group plc Ordinary Shares has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marex Group plc Ordinary Shares$2.02B2.39$307.20M$6.1010.89
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A

Marex Group plc Ordinary Shares has a net margin of 17.88% compared to abrdn Healthcare Investors' net margin of 0.00%. Marex Group plc Ordinary Shares' return on equity of 27.93% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
Marex Group plc Ordinary Shares17.88% 27.93% 1.13%
abrdn Healthcare Investors N/A N/A N/A

Marex Group plc Ordinary Shares presently has a consensus target price of $83.75, indicating a potential upside of 26.13%. Given Marex Group plc Ordinary Shares' stronger consensus rating and higher probable upside, equities research analysts clearly believe Marex Group plc Ordinary Shares is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marex Group plc Ordinary Shares
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Marex Group plc Ordinary Shares has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market. Comparatively, abrdn Healthcare Investors has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

Marex Group plc Ordinary Shares pays an annual dividend of $0.64 per share and has a dividend yield of 1.0%. abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 12.0%. Marex Group plc Ordinary Shares pays out 10.5% of its earnings in the form of a dividend.

Summary

Marex Group plc Ordinary Shares beats abrdn Healthcare Investors on 9 of the 15 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Federated Hermes?

abrdn Healthcare Investors (NYSE:HQH) and Federated Hermes (NYSE:FHI) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Federated Hermes has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A
Federated Hermes$1.80B2.51$403.30M$5.5411.01

In the previous week, abrdn Healthcare Investors had 3 more articles in the media than Federated Hermes. MarketBeat recorded 4 mentions for abrdn Healthcare Investors and 1 mentions for Federated Hermes. Federated Hermes' average media sentiment score of 0.96 beat abrdn Healthcare Investors' score of 0.60 indicating that Federated Hermes is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
abrdn Healthcare Investors
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Federated Hermes
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 12.0%. Federated Hermes pays an annual dividend of $1.52 per share and has a dividend yield of 2.5%. Federated Hermes pays out 27.4% of its earnings in the form of a dividend. Federated Hermes has raised its dividend for 4 consecutive years.

Federated Hermes has a consensus target price of $60.80, suggesting a potential downside of 0.35%. Given Federated Hermes' stronger consensus rating and higher possible upside, analysts plainly believe Federated Hermes is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Federated Hermes
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.38

32.6% of abrdn Healthcare Investors shares are held by institutional investors. Comparatively, 75.9% of Federated Hermes shares are held by institutional investors. 7.3% of abrdn Healthcare Investors shares are held by insiders. Comparatively, 4.2% of Federated Hermes shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Federated Hermes has a net margin of 21.28% compared to abrdn Healthcare Investors' net margin of 0.00%. Federated Hermes' return on equity of 33.94% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
abrdn Healthcare InvestorsN/A N/A N/A
Federated Hermes 21.28%33.94%18.30%

abrdn Healthcare Investors has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market. Comparatively, Federated Hermes has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Summary

Federated Hermes beats abrdn Healthcare Investors on 10 of the 15 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Piper Sandler Companies?

abrdn Healthcare Investors (NYSE:HQH) and Piper Sandler Companies (NYSE:PIPR) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

abrdn Healthcare Investors has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market. Comparatively, Piper Sandler Companies has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Piper Sandler Companies has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A
Piper Sandler Companies$1.90B2.40$281.33M$4.2515.32

Piper Sandler Companies has a consensus price target of $84.00, indicating a potential upside of 29.05%. Given Piper Sandler Companies' stronger consensus rating and higher probable upside, analysts clearly believe Piper Sandler Companies is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Piper Sandler Companies
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17

Piper Sandler Companies has a net margin of 14.53% compared to abrdn Healthcare Investors' net margin of 0.00%. Piper Sandler Companies' return on equity of 21.14% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
abrdn Healthcare InvestorsN/A N/A N/A
Piper Sandler Companies 14.53%21.14%13.98%

In the previous week, abrdn Healthcare Investors had 4 more articles in the media than Piper Sandler Companies. MarketBeat recorded 4 mentions for abrdn Healthcare Investors and 0 mentions for Piper Sandler Companies. abrdn Healthcare Investors' average media sentiment score of 0.60 beat Piper Sandler Companies' score of 0.00 indicating that abrdn Healthcare Investors is being referred to more favorably in the media.

Company Overall Sentiment
abrdn Healthcare Investors Positive
Piper Sandler Companies Neutral

32.6% of abrdn Healthcare Investors shares are owned by institutional investors. Comparatively, 72.8% of Piper Sandler Companies shares are owned by institutional investors. 7.3% of abrdn Healthcare Investors shares are owned by company insiders. Comparatively, 3.1% of Piper Sandler Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 12.0%. Piper Sandler Companies pays an annual dividend of $0.80 per share and has a dividend yield of 1.2%. Piper Sandler Companies pays out 18.8% of its earnings in the form of a dividend. Piper Sandler Companies has increased its dividend for 1 consecutive years.

Summary

Piper Sandler Companies beats abrdn Healthcare Investors on 10 of the 15 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Lazard?

abrdn Healthcare Investors (NYSE:HQH) and Lazard (NYSE:LAZ) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 12.0%. Lazard pays an annual dividend of $2.00 per share and has a dividend yield of 5.1%. Lazard pays out 121.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

abrdn Healthcare Investors has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market. Comparatively, Lazard has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market.

Lazard has a consensus target price of $46.50, suggesting a potential upside of 18.81%. Given Lazard's stronger consensus rating and higher probable upside, analysts clearly believe Lazard is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Lazard
3 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.10

Lazard has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A
Lazard$3.10B1.51$236.83M$1.6523.72

32.6% of abrdn Healthcare Investors shares are held by institutional investors. Comparatively, 54.8% of Lazard shares are held by institutional investors. 7.3% of abrdn Healthcare Investors shares are held by insiders. Comparatively, 1.0% of Lazard shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Lazard has a net margin of 5.55% compared to abrdn Healthcare Investors' net margin of 0.00%. Lazard's return on equity of 20.76% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
abrdn Healthcare InvestorsN/A N/A N/A
Lazard 5.55%20.76%4.16%

In the previous week, Lazard had 3 more articles in the media than abrdn Healthcare Investors. MarketBeat recorded 7 mentions for Lazard and 4 mentions for abrdn Healthcare Investors. abrdn Healthcare Investors' average media sentiment score of 0.60 beat Lazard's score of 0.09 indicating that abrdn Healthcare Investors is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
abrdn Healthcare Investors
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Lazard
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Lazard beats abrdn Healthcare Investors on 10 of the 14 factors compared between the two stocks.

How does abrdn Healthcare Investors compare to Moelis & Company?

abrdn Healthcare Investors (NYSE:HQH) and Moelis & Company (NYSE:MC) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

Moelis & Company has a net margin of 14.22% compared to abrdn Healthcare Investors' net margin of 0.00%. Moelis & Company's return on equity of 39.62% beat abrdn Healthcare Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
abrdn Healthcare InvestorsN/A N/A N/A
Moelis & Company 14.22%39.62%17.34%

In the previous week, abrdn Healthcare Investors had 4 more articles in the media than Moelis & Company. MarketBeat recorded 4 mentions for abrdn Healthcare Investors and 0 mentions for Moelis & Company. abrdn Healthcare Investors' average media sentiment score of 0.60 beat Moelis & Company's score of 0.23 indicating that abrdn Healthcare Investors is being referred to more favorably in the media.

Company Overall Sentiment
abrdn Healthcare Investors Positive
Moelis & Company Neutral

Moelis & Company has a consensus price target of $68.17, suggesting a potential upside of 24.86%. Given Moelis & Company's stronger consensus rating and higher possible upside, analysts plainly believe Moelis & Company is more favorable than abrdn Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
abrdn Healthcare Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Moelis & Company
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

abrdn Healthcare Investors pays an annual dividend of $2.47 per share and has a dividend yield of 12.0%. Moelis & Company pays an annual dividend of $2.60 per share and has a dividend yield of 4.8%. Moelis & Company pays out 88.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Moelis & Company has raised its dividend for 1 consecutive years.

abrdn Healthcare Investors has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, Moelis & Company has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

Moelis & Company has higher revenue and earnings than abrdn Healthcare Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Healthcare InvestorsN/AN/AN/AN/AN/A
Moelis & Company$1.52B2.81$233.04M$2.9418.57

32.6% of abrdn Healthcare Investors shares are owned by institutional investors. Comparatively, 91.5% of Moelis & Company shares are owned by institutional investors. 7.3% of abrdn Healthcare Investors shares are owned by insiders. Comparatively, 6.3% of Moelis & Company shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Moelis & Company beats abrdn Healthcare Investors on 10 of the 15 factors compared between the two stocks.

Get abrdn Healthcare Investors News Delivered to You Automatically

Sign up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HQH vs. The Competition

Metricabrdn Healthcare InvestorsCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$1.18B$4.93B$13.32B$22.19B
Dividend Yield11.70%5.62%4.97%3.82%
P/E RatioN/A24.0820.0829.10
Price / Sales4.637.935.013.42
Price / CashN/A29.5020.1615.54
Price / BookN/A1.731.763.65
Net IncomeN/A$419.50M$1.32B$1.07B
7 Day Performance-6.80%-2.69%-2.71%-4.52%
1 Month Performance8.18%-2.58%-2.07%-2.75%
1 Year Performance9.01%-2.27%4.55%5.41%

abrdn Healthcare Investors Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HQH
abrdn Healthcare Investors
N/A$20.57
-0.1%
N/A+8.7%$1.18B$253.93MN/A147,000
MRX
Marex Group plc Ordinary Shares
4.9277 of 5 stars
$69.26
+2.0%
$83.75
+20.9%
N/A$4.95B$2.02B11.353,109
FHI
Federated Hermes
1.988 of 5 stars
$65.53
+0.9%
$60.80
-7.2%
+27.2%$4.80B$1.80B11.722,091
PIPR
Piper Sandler Companies
4.5915 of 5 stars
$66.59
-1.6%
$84.00
+26.2%
-17.2%$4.75B$1.90B14.611,858
LAZ
Lazard
3.9716 of 5 stars
$41.01
+3.7%
$46.50
+13.4%
-18.1%$4.72B$3.10B23.263,309

Related Companies and Tools


This page (NYSE:HQH) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners